Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (6) Blankenstein, Thomas Prof. Dr. (179) Bunse, Mario Dr. (3) Cakmak-Görür, Nese Dr. (1) Clauß, Julian (1) Daniel, Peter Prof. Dr. (4) Dhamodaran, Arunraj (2) Dyck, Lydia Dr. (1) Filosa, Alessandro Dr. (1) Gerhardt, Holger Prof. Dr. (1) Henssen, Anton Prof. Dr. med. (1) Höpken, Uta Elisabeth PD Dr. (2) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Jeuthe, Sarah Dr. (1) Kammertöns, Thomas Dr. (38) Keller, Ulrich Dr. med. (1) Kieback, Elisa Dr. (3) Kopp, Joachim Dr. (5) Kühn, Ralf Dr. (1) Kunz, Severine Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (10) Lorenz, Felix Dr. (1) Marko, Lajos Dr. (1) Mertins, Philipp Dr. (3) Na, Il-Kang Dr. (2) Nguyen, Tam Hoai Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (17) Poncette, Lucia (4) Popp, Oliver Dr. (3) Rahn, Hans-Peter Dr. (1) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Rhein, Simone Dr. (2) Richter, Matthias (1) Rosenberger, Leonie Milena (1) Sawamiphak, Suphansa Dr. (1) Schlag, Peter M. Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Schütz, Anja Dr. (1) Siffrin, Volker (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (3) Uckert, Wolfgang Prof. Dr. (23) Walther, Wolfgang Prof. Dr. (7) Wolf, Susanne Dr. (2) (-) Willimsky, Gerald Dr. (34) 1997 (1) 1998 (1) 2000 (3) 2002 (1) 2005 (4) 2007 (1) 2008 (2) 2010 (4) 2011 (1) 2013 (5) 2017 (1) 2018 (3) 2019 (2) 2021 (1) 2022 (2) 2023 (2) Advanced Light Microscopy (1) AG Müller/Dechend (ECRC) (3) Anchored Signalling (1) Animal Phenotyping (2) Bioinformatics and Omics Data Science (9) Cell Biology of Immunity (1) Clinic of Psychiatry / Modul Psychiatry of Aging (1) Computational methodologies and omic analytics (1) Computational Regulatory Genomics (5) Developmental Biology / Signal Transduction (7) Development and Function of Neural Circuits (1) Epigenetic Modifications in Neuroblastoma (1) Epigenetic Regulation and Chromatin Architecture (2) Flow Cytometry (2) From Cell States to Function (4) Gastrointestinal Barrier, Regeneration and Carcinogenesis (1) Genetics and Genomics of Cardiovascular Diseases (5) Genome Diversification & Integrity (1) Genome Engineering & Disease Models (3) Genomics (4) Hypertension-caused End-Organ Damage (3) Hypertension-Mediated End-Organ Damage (3) Immune Regulation and Cancer (3) Integrative Vascular Biology (1) Intracellular Proteolysis (1) Mathematical Cell Physiology (2) Mechanism-based Cancer Therapies (1) Microenvironmental Regulation in Autoimmunity and Cancer (3) Molecular and cellular basis of behavio (1) Molecular Biology of Peptide Hormones (5) Molecular Cardiovascular Research (3) (-) Molecular Immunology and Gene Therapy (34) Molecular Pathways in Cortical Development (2) Molecular Physiology of Somatic Sensation (5) Myology (3) Neuroimmunology Laboratory (1) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (3) Organoids (8) Pluripotent Stem Cells (2) Protein Production and Characterization (1) Proteome Dynamics (9) Proteomics (4) Proteomics and Metabolomics (7) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (5) Psychoneuroimmunology (1) Quantitative Developmental Biology (2) Quantitative Stem Cell Biology (1) RNA Biology and Posttranscriptional Regulation (19) Systems Biology Imaging (5) Systems Biology of Gene Regulatory Elements (160) Transgenics (3) Translational Bioinformatics (5) Translational Cardiology and Functional Genomics (2) Translational Oncology of Solid Tumors (1) Translational Tumorimmunology (2) 34 Results: Active Filter: Willimsky, Gerald Dr.Molecular Immunology and Gene Therapy Sort: Result score Newest to oldest Oldest to newest April 20, 2021 / eLife In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo G. Willimsky C. Beier L. Immisch G. Papafotiou V. Scheuplein-Schlosser A. Goede H.G. Holzhütter T. Blankenstein P.M. Kloetzel April 06, 2022 / Cancers Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires C. Grunert G. Willimsky C.A. Peuker S. Rhein L. Hansmann T. Blankenstein E. Blanc D. Beule U. Keller A. Pezzutto A. Busse August 30, 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky November 27, 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule June 01, 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel August 01, 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein April 01, 2019 / Leukemia Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies N. Çakmak-Görür J. Radke S. Rhein E. Schumann G. Willimsky F.L. Heppner T. Blankenstein A. Pezzutto February 01, 2017 / Canc Immunol Res Tumor-infiltrating merkel cell polyomavirus-specific T cells are diverse and associated with improved patient survival N.J. Miller C.D. Church L. Dong D. Crispin M.P. Fitzgibbon K. Lachance L. Jing M. Shinohara I. Gavvovidis G. Willimsky M. McIntosh T. Blankenstein D.M. Koelle P. Nghiem October 27, 2022 / J Immunother Cancer H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky March 14, 2023 / J Immunother Cancer Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
April 20, 2021 / eLife In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo G. Willimsky C. Beier L. Immisch G. Papafotiou V. Scheuplein-Schlosser A. Goede H.G. Holzhütter T. Blankenstein P.M. Kloetzel
April 06, 2022 / Cancers Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires C. Grunert G. Willimsky C.A. Peuker S. Rhein L. Hansmann T. Blankenstein E. Blanc D. Beule U. Keller A. Pezzutto A. Busse
August 30, 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky
November 27, 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule
June 01, 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel
August 01, 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein
April 01, 2019 / Leukemia Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies N. Çakmak-Görür J. Radke S. Rhein E. Schumann G. Willimsky F.L. Heppner T. Blankenstein A. Pezzutto
February 01, 2017 / Canc Immunol Res Tumor-infiltrating merkel cell polyomavirus-specific T cells are diverse and associated with improved patient survival N.J. Miller C.D. Church L. Dong D. Crispin M.P. Fitzgibbon K. Lachance L. Jing M. Shinohara I. Gavvovidis G. Willimsky M. McIntosh T. Blankenstein D.M. Koelle P. Nghiem
October 27, 2022 / J Immunother Cancer H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky
March 14, 2023 / J Immunother Cancer Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky